Literature DB >> 9165483

Ultrastructural localization of butyrylcholinesterase in senile plaques in the brains of aged and Alzheimer disease patients.

P Gómez-Ramos1, M A Morán.   

Abstract

Histochemical localization of butyrylcholinesterase has been carried out in primitive, perivascular, and classic plaques in the brains of both nondemented and Alzheimer disease (AD) patients. Butyrylcholinesterase histochemistry has been compared to amyloid beta-protein (A beta P) immunocytochemistry in adjacent sections. In small primitive plaques, most of the butyrylcholinesterase reaction product appears ultrastructurally located over plasma membranes of healthy-looking cell processes. In more extensive primitive plaques, butyrylcholinesterase reaction product also decorates amyloid filaments, which become identifiable as delicate wisps. In classic plaques, large aggregates of butyrylcholinesterase reaction product colocalize with bundles of amyloid filaments, as well as with the compact amyloid core. Thus, deposition of butyrylcholinesterase in senile plaques follows a close parellelism with the progressive aggregation of amyloid beta-protein, supporting the possibility that cholinesterases may play some role in the maturation of these structures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9165483     DOI: 10.1007/bf02815095

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  10 in total

1.  Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

Authors:  Bin He; Sylvia E Perez; Sang H Lee; Stephen D Ginsberg; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2020-05-05       Impact factor: 3.215

2.  Ovariectomy enhances acetylcholinesterase activity but does not alter ganglioside content in cerebral cortex of female adult rats.

Authors:  Siomara C Monteiro; Francieli M Stefanello; Luciene P Vianna; Cristiane Matte; Jaqueline Barp; Adriane Belló-Klein; Vera M T Trindade; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

3.  Homocysteine inhibits butyrylcholinesterase activity in rat serum.

Authors:  Francieli M Stefanello; Alexandra I Zugno; Clovis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2003-09       Impact factor: 3.584

4.  In vitro homocysteine inhibits platelet Na+,K+-ATPase and serum butyrylcholinesterase activities of young rats.

Authors:  Francieli M Stefanello; Renata Franzon; Clovis M D Wannmacher; Moacir Wajner; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2003-12       Impact factor: 3.584

5.  Supplementation with vitamins E plus C or soy isoflavones in ovariectomized rats: effect on the activities of Na(+), K (+)-ATPase and cholinesterases.

Authors:  Siomara C Monteiro; Cristiane B Mattos; Emilene B S Scherer; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2007-05-19       Impact factor: 3.584

6.  Anticholinesterase and Antioxidative Properties of Aqueous Extract of Cola acuminata Seed In Vitro.

Authors:  Ganiyu Oboh; Ayodele J Akinyemi; Olasunkanmi S Omojokun; Idowu S Oyeleye
Journal:  Int J Alzheimers Dis       Date:  2014-11-18

Review 7.  Strategies for Continued Successful Treatment in Patients with Alzheimer's Disease: An Overview of Switching Between Pharmacological Agents.

Authors:  Rafael Blesa; Kazuhiro Toriyama; Kengo Ueda; Sean Knox; George Grossberg
Journal:  Curr Alzheimer Res       Date:  2018       Impact factor: 3.498

8.  Altered levels of variant cholinesterase transcripts contribute to the imbalanced cholinergic signaling in Alzheimer's and Parkinson's disease.

Authors:  Muslum Gok; Nimrod Madrer; Tamara Zorbaz; Estelle R Bennett; David Greenberg; David A Bennett; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2022-09-02       Impact factor: 6.261

9.  Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer's disease treatment.

Authors:  Sani Muhammad Uzairu; Yahaya Tijani; Madu Adamu Gadaka; Babagana Modu; Miriam Watafua; Hadiza Ali Ahmad; Umar Abdullahi Zakariya; Aminu Ibrahim; Aliyu Daja; Hassan Zanna; Abdullahi Balarabe Sallau
Journal:  Heliyon       Date:  2022-09-13

10.  The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology.

Authors:  Erez Podoly; Deborah E Shalev; Shani Shenhar-Tsarfaty; Estelle R Bennett; Einor Ben Assayag; Harvey Wilgus; Oded Livnah; Hermona Soreq
Journal:  J Biol Chem       Date:  2009-04-21       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.